0001213900-20-045807.txt : 20201231
0001213900-20-045807.hdr.sgml : 20201231
20201231172400
ACCESSION NUMBER: 0001213900-20-045807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201229
FILED AS OF DATE: 20201231
DATE AS OF CHANGE: 20201231
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danenberg Noam
CENTRAL INDEX KEY: 0001720898
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52545
FILM NUMBER: 201429498
MAIL ADDRESS:
STREET 1: 4 BOROCHOV ST
CITY: HOD HASHARON
STATE: L3
ZIP: 4520404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wize Pharma, Inc.
CENTRAL INDEX KEY: 0001218683
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880445167
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 24 HANAGAR ST
CITY: HOD HASHARON
STATE: L3
ZIP: 4527713
BUSINESS PHONE: 972 472 260 0536
MAIL ADDRESS:
STREET 1: 24 HANAGAR ST
CITY: HOD HASHARON
STATE: L3
ZIP: 4527713
FORMER COMPANY:
FORMER CONFORMED NAME: OphthaliX, Inc.
DATE OF NAME CHANGE: 20120207
FORMER COMPANY:
FORMER CONFORMED NAME: DENALI CONCRETE MANAGEMENT INC
DATE OF NAME CHANGE: 20030213
4
1
ownership.xml
X0306
4
2020-12-29
0
0001218683
Wize Pharma, Inc.
WIZP
0001720898
Danenberg Noam
C/O WIZE PHARMA, INC.
24 HANAGAR STREET
HOD HASHARON
L3
4527708
ISRAEL
1
1
0
0
Chief Executive Officer
Common Stock
2020-12-29
4
X
0
125000
A
1077681
D
Common Stock
2020-12-29
4
S
0
962
D
1076719
D
Common Stock
2020-12-29
4
X
0
1505162
A
2581881
I
See Footnote
Common Stock
2020-12-29
4
S
0
12543
D
2569338
I
See Footnote
Common Stock
2020-12-29
4
X
0
173607
A
2742945
I
See Footnote
Common Stock
2020-12-29
4
S
0
1447
D
2741498
I
See Footnote
Common Stock
2020-12-29
4
X
0
63236
A
2804734
I
See Footnote
Common Stock
2020-12-29
4
S
0
507
D
2804227
I
See Footnote
Warrant (right to buy)
0.16
2020-12-29
4
X
0
125000
0
D
2019-04-21
2023-10-23
Common Stock
125000
0
D
Warrant (right to buy)
0.27
2020-12-29
4
X
0
1505162
0
D
2024-12-12
Common Stock
1505162
0
I
See Footnote
Warrant (right to buy)
0.16
2020-12-29
4
X
0
173607
0
D
2019-05-31
2021-05-30
Common Stock
173607
0
I
See Footnote
Future Investment Rights
0.27
2020-12-29
4
X
0
63236
0
D
2019-12-13
2024-12-12
Common Stock
63236
0
I
See Footnote
On December 23, 2020 the registrant has voluntary reduced the exercise price of warrants to $0.001. The reporting person exercised a warrant to purchase shares of the registrant's common stock for the reduced exercise price.
On December 29, 2020 the reporting person exercised a warrant to purchase 125,000 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 962 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 124,038 shares.
On December 29, 2020 the reporting person exercised a warrant to purchase 1,505,162 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 12,543 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,492,619 shares.
On December 29, 2020 the reporting person exercised a warrant to purchase 173,607 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 1,447 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,160 shares.
On December 29, 2020 the reporting person exercised a warrant to purchase 63,236 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 507 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 62,729 shares.
Securities held by Mobigo Inc.
Exercisable five days following the public announcement of positive clinical data results for LO2A.
/s/ Noam Dannenberg
2020-12-31